Literature DB >> 719346

Heparin and infusion phlebitis.

J R Stradling.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 719346      PMCID: PMC1608302          DOI: 10.1136/bmj.2.6146.1195

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Venous thrombosis during dextrose infusion.

Authors:  D W VERE; C H SYKES; P ARMITAGE
Journal:  Lancet       Date:  1960-09-17       Impact factor: 79.321

2.  Postinfusion phlebitis.

Authors:  E T Thomas; W Evers; G B Racz
Journal:  Anesth Analg       Date:  1970 Jan-Feb       Impact factor: 5.108

3.  Continuous venous catheterization in children.

Authors:  A R Hohn; E C Lambert
Journal:  JAMA       Date:  1966-08-22       Impact factor: 56.272

4.  The utilization of long nylon catheters for prolonged intravenous infusions.

Authors:  R B Roy; R H Wilkinson; C E Bayliss
Journal:  Can Med Assoc J       Date:  1967-01-14       Impact factor: 8.262

5.  Infusion thrombophlebitis and infection with various cannulas.

Authors:  J Collin; C Collin; F L Constable; I D Johnston
Journal:  Lancet       Date:  1975-07-26       Impact factor: 79.321

  5 in total
  4 in total

Review 1.  Potential for extending survival of peripheral intravenous infusions.

Authors:  J F Hecker
Journal:  BMJ       Date:  1992-03-07

2.  Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials.

Authors:  A G Randolph; D J Cook; C A Gonzales; M Andrew
Journal:  BMJ       Date:  1998-03-28

3.  Simplified intravenous nutrition using Intralipid-based mixtures in patients with serious gastrointestinal disease.

Authors:  W R Burnham; C E Knott; J A Cook; M J Langman
Journal:  Postgrad Med J       Date:  1983-06       Impact factor: 2.401

4.  The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas.

Authors:  C Jorup-Rönström; S Britton; A Gavlevik; K Gunnarsson; A C Redman
Journal:  Infection       Date:  1984 Nov-Dec       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.